Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Cancer of Pancreas

etoposide has been researched along with Cancer of Pancreas in 102 studies

Research

Studies (102)

TimeframeStudies, this research(%)All Research%
pre-19904 (3.92)18.7374
1990's17 (16.67)18.2507
2000's39 (38.24)29.6817
2010's36 (35.29)24.3611
2020's6 (5.88)2.80

Authors

AuthorsStudies
Endo, S; Fujiwara, Y; Higashida, M; Iwamoto, R; Katada, Y; Kinoshita, S; Kitagawa, S; Kubota, H; Mineta, S; Okada, T; Sanuki, F; Tanaka, H; Ueno, M; Ueno, T; Yoshimatsu, K1
Albers, D; Kasper, S; Lahner, H; Markus, P; Mende, B; Mika, S; Reis, H; Rosery, V; Schmid, KW; Schuler, M; Schumacher, B; Siveke, JT; Stuschke, M; Treckmann, J; Wiesweg, M1
Chan, WT; Hou, JY; Jiang, CB; Lee, HC; Liu, HC; Liu, YC; Sheu, JC; Wu, PS; Yeh, TC; Yeung, CY1
Di Sabatino, A; Furlan, D; La Rosa, S; Martino, M; Neri, G; Perfetti, V; Sessa, F; Solcia, E; Vanoli, A; Viglio, A1
Afchain, P; Baudin, E; Desgrippes, R; Hadoux, J; Hautefeuille, V; Lepage, C; Lorgis, V; Monterymard, C; Scoazec, JY; Thuillier, F; Tougeron, D; Walter, T1
Alonso-Gordoa, T; Brabander, T; Cadiot, G; Caminoa, A; Capdevila, J; Chakrabarty, B; Couvelard, A; Cros, J; de Mestier, L; García Gómez-Muriel, MI; Garcia-Alvarez, A; Hernando, J; Kats-Ugurlu, G; Lamarca, A; Landolfi, S; Manoharan, P; Pavel, ME; Perrier, M; Ronot, M; Van Velthuysen, MF; Walenkamp, AM; Zandee, W1
Aparicio, T; Baudin, E; Bonnet, I; Cadiot, G; Coriat, R; Dahan, L; Desauw, C; Guimbaud, R; Hentic, O; Le Malicot, K; Lecomte, T; Legoux, JL; Lepage, C; Lepère, C; Lombard-Bohas, C; Malka, D; Manfredi, S; Roquin, G; Scoazec, JY; Thirot-Bidault, A; Tougeron, D; Walter, T1
Barbera, MA; Biasco, G; Bondi, A; Brandi, G; Brighi, N; Campana, D; Corbelli, J; Pantaleo, MA; Paragona, M1
Itai, R; Yamashita, Y; Yokode, M; Zen, Y1
Ali, AS; Grönberg, M; Grønbæk, H; Hjortland, GO; Janson, ET; Knigge, U; Ladekarl, M; Langer, SW; Österlund, P; Sorbye, H; Vestermark, LW; Welin, S1
Beck, Y; Komagome, M; Maki, A; Mitsui, T; Miyata, Y; Nakazawa, A; Ninomiya, R; Ozawa, F1
Boudreaux, JP; Ramirez, RA; Thiagarajan, R; Thomas, KEH; Voros, BA; Woltering, EA1
Laczkó, D; Marchand, B; Pitarresi, JR; Reichert, M; Rustgi, AK; Suzuki, K1
Hwang, J; Kim, DW; Lee, EJ1
Duque, M; Gupta, A; Saif, MW1
Frikha, M; Khanfir, A; Kridis, WB; Triki, F1
Huang, Q; Zhang, SH1
Stone, MS; Tschetter, AJ; VanBeek, MJ1
Ikeda, M; Kondo, S; Mitsunaga, S; Morizane, C; Ohno, I; Okusaka, T; Okuyama, H; Shimizu, S; Takahashi, H; Ueno, H1
Alexandrow, MG; Bryant, VL; Elias, RM; McCarthy, SM; Yeatman, TJ1
Barriuso, J; Borbath, I; Chougnet, CN; Crespo, G; Heetfeld, M; O'Toole, D; Olsen, IH; Pavel, M; Rinke, A; Walter, T1
Ahn, SI; Lee, KY; Park, KM; Park, SY; Shin, WY1
Asai, K; Asayama, Y; Honda, H; Matsumoto, K; Nakamura, K; Nishie, A; Ohga, S; Sasaki, T; Shinoto, M; Shioyama, Y; Terashima, K; Yoshitake, T1
Fazio, N; Milione, M1
Adamenko, O; Belfiori, G; Cardinali, L; Crippa, S; Doglioni, C; Falconi, M; Muffatti, F; Palucci, M; Partelli, S; Zamboni, G1
Bhagat, VH; Sepe, T1
Ammerpohl, O; Fölsch, UR; Kalthoff, H; Koch, D; Müerköster, SS; Schäfer, H; Sipos, B; Tsao, MS; Werbing, V1
Anders, K; Gottlieb, K; Kaya, H1
Fu, M; Li, X; Li, Y; Liang, X; Lin, C; Liu, Y; Qian, H; Wang, H; Yu, J; Zhan, Q; Zhang, X1
Altevogt, P; Fölsch, UR; Gast, D; Geismann, C; Kötteritzsch, J; Kruse, ML; Schäfer, H; Sebens Müerköster, S1
Egami, T; Matsumoto, K; Miyoshi, K; Mizumoto, K; Ohuchida, K; Onimaru, M; Sato, N; Tanaka, M; Toma, H1
Chikugo, T; Kitano, M; Komaki, T; Kudo, M; Noda, K; Sakamoto, H1
Fritsche, P; Göttlicher, M; Saur, D; Schmid, RM; Schneider, G; Schnieke, A; Schüler, S; Seidler, B1
Egan, A; Khan, MF; Martin, ST; Ryan, RS; Tobbia, I; Waldron, R; Walshe, T1
Chen, X; Huang, Q; Li, C; Li, J; Liu, X; Qiu, Z; Tian, Y; Wang, Y; Wolf, F; Xie, K; Xu, P; Zhang, D1
Hagihara, A; Hiraoka, N; Ikeda, M; Iwasa, S; Kojima, Y; Kondo, S; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Tanaka, T; Ueno, H1
Du, ZX; Gao, YY; Liu, BQ; Meng, X; Niu, XF; Wang, HQ; Zhang, HY1
Dilnawaz, F; Mohanty, AK; Mohanty, C; Sahoo, SK1
Bassett, MR; Bedolla, G; Campbell, AD; Davis, AT; Koo, HM; Luttenton, CR; Melnik, MK; Monroe, TJ; O'Rourke, TJ; Richardson, PJ; Stein, P; Szczepanek, CM; Truszkowski, KJ; Van Brocklin, MW; Vande Woude, GF; Webb, CP; Yost, KJ1
Araki, M; Hasegawa, H; Itoh, M; Kodama, Y; Kuzushita, N; Mano, M; Mita, E; Morita, K; Nakazuru, S; Ohta, M; Ohta, T; Suemura, S; Sueyoshi, Y; Toyama, T; Yoshio, T; Yoshioka, C1
Sorscher, SM1
Asha, HS; Chacko, RT; Eapen, A; Fleming, JJ; Hepzibah, J; Kapoor, N; Ramakrishna, B; Somasundaram, N; Thomas, N1
Couvelard, A; de Gramont, A; Faivre, S; Hammel, P; Neuzillet, C; Raymond, E; Serova, M; Tijeras-Raballand, A1
Couvelard, A; Gillet, A; Goujon, G; Hammel, P; Hentic, O; Lévy, P; Maire, F; Palazzo, M; Rebours, V; Ruszniewski, P; Zappa, M1
Dirnhofer, S; Girsberger, S; Karow, A; Lehmann, T; Lundberg, P; Passweg, JR; Rovó, A; Skoda, R; Tichelli, A1
Arlt, A; Geismann, C; Grossmann, M; Krebs, S; Kruse, ML; Schäfer, H; Schreiber, S; Sebens, S1
Algül, H; Conradt, L; Henrich, A; Krämer, OH; Lesina, M; Reichert, M; Saur, D; Schmid, RM; Schneider, G; Wirth, M1
Chen, J; Huang, XY; Tang, J; Yang, Z; Yuan, Z; Zheng, Q1
Campitiello, M; Plastino, F; Treglia, G1
Ali, S; Biris, A; Casciano, D; Dantuluri, V; Karmakar, A; Mahmood, M; Mustafa, T; Xu, Y; Zhang, Y1
Chao, Y; Chen, LT; King, KL; Lan, C; Li, AF; Lin, WC; Liu, JM; Perng, CL; Tiu, CM; Whang-Peng, J1
Auroux, J; Bernardeau, M; Cavicchi, M; Delchier, JC; Haioun, C; Tsakiris, L1
Arlt, A; Fölsch, UR; Gehrz, A; Grohmann, F; Haye, S; Kalthoff, H; March, C; Müerköster, S; Schäfer, H; Wegehenkel, K; Witt, M1
Hosoya, Y; Kaneko, Y; Koinuma, K; Nagai, H; Saito, K; Yasuda, Y1
Arlt, A; Fölsch, UR; Gehrz, A; Kruse, ML; Müerköster, S; Schäfer, H; Vorndamm, J1
Ikenaga, SK; Maruyama, M; Odagiri, H; Sasaki, M; Sato, T1
Chang, I; Cho, N; Koh, JY; Lee, MS1
Hoffarth, S; Huber, C; Milosevic, J; Schuler, M1
Faiss, S; Raue, F; Schaaf, L; Scherübl, H; Zeitz, M1
Arlt, A; Fölsch, UR; Gehrz, A; Grohmann, F; Müerköster, S; Schäfer, H; Vorndamm, J; Witt, M1
Arlt, A; Fölsch, UR; Grossmann, M; Kalthoff, H; Klöppel, G; Müerköster, S; Schäfer, H; Sipos, B; Witt, M1
Akazawa, Y; Isomoto, H; Kohno, S; Mizuta, Y; Nakagoe, T; Ohara, H; Ohba, K; Ohnita, K; Omagari, K; Shiozawa, K; Shirono, K; Takeshima, F; Tanaka, K; Yasutake, T1
Brody, JR; Cunningham, SC; DeMarzo, AM; Dezentje, DA; Gallmeier, E; Hruban, RH; Isacoff, WH; Kern, SE; Offerhaus, GJ; Swartz, MJ; van der Heijden, MS1
Dalal, BI; Kollmannsberger, C; McArthur, HL1
Altevogt, P; Debus, MA; Fölsch, UR; Grossmann, M; Kappes, H; Klöppel, G; Kötteritzsch, J; Leisner, D; Schäfer, H; Sebens Müerköster, S; Sipos, B; Werbing, V; Witt, M1
Knight, PJ; Schutte, WP1
Kim, DM; Lee, S; Lim, SK; Park, SY; Park, YN; Rhee, Y; Song, SY; Youn, JC1
Cinaz, P; Yeşilkaya, E1
Chatelain, D; Delcenserie, R; Flamant, M; Fuks, D; Regimbeau, JM; Sabbagh, C; Yzet, T1
Becker, H; Lübbert, M; Schäfer, HS; Schmitt-Gräff, A1
Bloom, SR; Hammond, PJ1
Asbury, RF; Cnaan, A; Haller, DG; Harris, J; Johnson, L; Zaentz, SD1
Bajetta, E; Di Bartolomeo, M; Di Leo, A; Zampino, MG1
Hord, JD; Janco, RL1
Fujiki, T; Suda, Y1
Conroy, T; Curran, D; de Graeff, A; Hoogenraad, WJ; Lusinchi, A; Rougier, P; Sahmoud, T; Taal, BG; Veenhof, CH; Wagener, DJ; Wils, J1
Enander, LK; Glimelius, B; Hoffman, K; Jacobsson, G; Linné, T; Sellström, H; Sjödén, PO; Svensson, C1
Aramaki, R; Mizumoto, K; Tanaka, M1
Oka, T; Sawabe, Y; Yamagishi, H; Yamaguchi, N; Yamamura, Y1
Akashi, T; Fukutomi, M; Funakoshi, A; Iguchi, H; Kuniyoshi, M; Ohnishi, Y; Wakasugi, H; Yokota, M1
Kusumoto, M; Mizumoto, K; Niiyama, H; Ogawa, T; Sato, N; Tanaka, M; Zhang, L1
Kusumoto, M; Mizumoto, K; Nakamura, M; Niiyama, H; Ogawa, T; Sato, N; Tanaka, M; Ueno, H1
Nortier, JW; Shamelian, SO1
Kusumoto, M; Maehara, N; Mizumoto, K; Nishio, S; Ogawa, T; Sato, N; Tanaka, M; Urashima, T1
Mitry, E; Rougier, P1
Yokoyama, A1
Chapman, RA; Gandara, DR; Jacobson, JL; Macdonald, JS; Modiano, M; Moore, DF; Schroder, LE1
Hattori, T; Imamura, T; Ito, T; Nakamura, K; Obana, K; Ogawa, B; Okinaga, K; Tanaka, F; Yanagawa, Y1
Arlt, A; Breitenbroich, M; Fölsch, UR; Kalthoff, H; Schäfer, H; Schmidt, WE; Vorndamm, J1
Fujiwara, M; Itou, Y; Kondoh, H; Konisi, I; Tanaka, K1
Arlt, A; Fölsch, UR; Müerköster, S; Schäfer, H; Schmidt, WE; Vorndamm, J; Yu, H1
Bach, FH; Berberat, PO; Brouard, S; Günther, L; Haga, M; Smith, RN; Soares, MP; Tobiasch, E1
Cooke-Yarborough, C; Martin, HC; Onikul, E; Sharathkumar, A; Shaw, PJ1
Eden, OB; Shaw, MP1
Bachy, B; Caillaud, JM; Flamant, F; Gruner, M; Hemet, J; Lefur, R; Lemerle, J; Tron, P; Vannier, JP1
Kvols, LK; Moertel, CG; O'Connell, MJ; Rubin, J1
Marshall, E; Metcalf, C; Trotter, JM1
Fujita, F; Fujita, M; Inaba, H; Okuyama, Y; Sugimoto, T; Taguchi, T1
Bruckner, HW; Morant, R1
Christiansen, NP; Kennedy, BJ1
Applewhite, A; Cheng, EW; Magill, GB; Sordillo, PP; Sternberg, CN1
Aota, Y; Kinjo, T; Mitsuya, H; Murase, T; Shimoji, T1

Reviews

12 review(s) available for etoposide and Cancer of Pancreas

ArticleYear
Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma.
    The oncologist, 2019, Volume: 24, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Intestinal Neoplasms; Irinotecan; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Stomach Neoplasms

2019
Treatment of poorly differentiated neuroendocrine carcinoma of the pancreas.
    JOP : Journal of the pancreas, 2013, Jul-10, Volume: 14, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Humans; Paclitaxel; Pancreatic Neoplasms; Receptor, IGF Type 1; TOR Serine-Threonine Kinases; Treatment Outcome

2013
Chemotherapy for advanced poorly differentiated pancreatic neuroendocrine carcinoma.
    Journal of hepato-biliary-pancreatic sciences, 2015, Volume: 22, Issue:8

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Neuroendocrine; Cisplatin; Drug Administration Schedule; Etoposide; Everolimus; Humans; Irinotecan; Pancreatic Neoplasms

2015
Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications.
    Cancer treatment reviews, 2016, Volume: 50

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cell Proliferation; Etoposide; Humans; Intestinal Neoplasms; Intestine, Small; Ki-67 Antigen; Neoplasm Grading; Pancreatic Neoplasms; Platinum Compounds; Prognosis; Stomach Neoplasms

2016
Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology.
    World journal of gastroenterology, 2016, Dec-07, Volume: 22, Issue:45

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cell Proliferation; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Ki-67 Antigen; Mitotic Index; Neoadjuvant Therapy; Neoplasm Staging; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Prognosis

2016
Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategies.
    Targeted oncology, 2012, Volume: 7, Issue:3

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Resistance, Neoplasm; Etoposide; Everolimus; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Medical Oncology; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Sirolimus; Sunitinib; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A

2012
Pseudomyxoma peritonei accompanied by intraductal papillary mucinous neoplasm of the pancreas.
    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2005, Volume: 5, Issue:4-5

    Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma, Pancreatic Ductal; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Peritoneal Neoplasms; Pseudomyxoma Peritonei

2005
[Effect of etoposide on a human pancreatic cancer cell line exposed to high dose X-ray irradiation].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Etoposide; Humans; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Tumor Cells, Cultured

1996
[A case of adult T cell leukemia (lymphoma type) involving the pancreas].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1999, Volume: 96, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Etoposide; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Pancreatic Neoplasms; Prednisolone; Remission Induction; Vincristine

1999
Chemotherapy in the treatment of neuroendocrine malignant tumors.
    Digestion, 2000, Volume: 62 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Doxorubicin; Etoposide; Fluorouracil; Gastrointestinal Neoplasms; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Streptozocin

2000
[Current status and future directions of gemcitabine in the treatment of non-small cell lung cancer and pancreatic cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:8

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase II as Topic; Deoxycytidine; Etoposide; Forecasting; Gemcitabine; Lung Neoplasms; Pancreatic Neoplasms

2000
[A case of small cell carcinoma of the pancreas].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2001, Volume: 98, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Phosphopyruvate Hydratase

2001

Trials

9 trial(s) available for etoposide and Cancer of Pancreas

ArticleYear
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2021, Volume: 53, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carcinoma, Neuroendocrine; Etoposide; Female; Fluorouracil; Humans; Intestinal Neoplasms; Irinotecan; Leucovorin; Male; Neoplasm Metastasis; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Oxaliplatin; Pancreatic Neoplasms; Platinum Compounds; Progression-Free Survival; Prospective Studies; Quality of Life; Stomach Neoplasms; Survival Rate; Treatment Outcome

2021
Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer.
    Molecular cancer therapeutics, 2010, Volume: 9, Issue:8

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Survival Analysis

2010
Palliative MEFLEP therapy in advanced pancreatic cancer: excellent response in a patient with Her-2/neu amplification.
    Pancreas, 2002, Volume: 25, Issue:1

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Female; Fluorouracil; Gene Amplification; Humans; Leucovorin; Male; Middle Aged; Palliative Care; Pancreatic Neoplasms; Receptor, ErbB-2

2002
An Eastern Cooperative Oncology Group phase II study of single agent DHAD, VP-16, aclacinomycin, or spirogermanium in metastatic pancreatic cancer.
    American journal of clinical oncology, 1994, Volume: 17, Issue:2

    Topics: Aclarubicin; Adenocarcinoma; Adjuvants, Immunologic; Antineoplastic Agents; Etoposide; Female; Humans; Male; Mitoxantrone; Organometallic Compounds; Pancreatic Neoplasms; Spiro Compounds; Survival Rate

1994
Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study.
    European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiotherapy; Survival Rate

1996
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Palliative Care; Pancreatic Neoplasms; Pilot Projects; Quality of Life; Survival Analysis

1996
A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) + G-CSF for patients with pancreatic adenocarcinoma: a Southwest Oncology Group study (SWOG 9413).
    Investigational new drugs, 2000, Volume: 18, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Interferon alpha-2; Interferon-alpha; Leucovorin; Male; Middle Aged; Pancreatic Neoplasms; Recombinant Proteins

2000
Combination chemotherapy with etoposide and 5-fluorouracil in advanced pancreatic adenocarcinoma.
    American journal of clinical oncology, 1989, Volume: 12, Issue:1

    Topics: Adenocarcinoma; Aged; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms

1989
Etoposide (VP-16) in the treatment of advanced adenocarcinoma of the pancreas.
    American journal of clinical oncology, 1988, Volume: 11, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Clinical Trials as Topic; Etoposide; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms

1988

Other Studies

81 other study(ies) available for etoposide and Cancer of Pancreas

ArticleYear
[A Case of Pancreas Neuroendocrine Carcinoma Achieved Long-Term Survival by Carboplatin plus Etoposide Therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2021, Volume: 48, Issue:13

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Fluorouracil; Humans; Male; Pancreas; Pancreatic Neoplasms

2021
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
    Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:8

    Topics: Etoposide; Gastrointestinal Neoplasms; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Platinum; Prognosis; Retrospective Studies; Stomach Neoplasms

2023
Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report.
    Medicine, 2022, Nov-25, Volume: 101, Issue:47

    Topics: Adolescent; Cyclophosphamide; Dysuria; Epirubicin; Etoposide; Flank Pain; Humans; Ifosfamide; Male; Pancreas; Pancreatic Neoplasms; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine

2022
Long Survival and Prolonged Remission after Surgery and Chemotherapy in a Metastatic Mismatch Repair Deficient Pancreatic Neuroendocrine Carcinoma with MLH1/PMS2 Immunodeficiency and Minimal Microsatellite Shift.
    Endocrine pathology, 2020, Volume: 31, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; DNA Mismatch Repair; Etoposide; Humans; Male; Microsatellite Instability; Middle Aged; Mismatch Repair Endonuclease PMS2; MutL Protein Homolog 1; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Pancreaticoduodenectomy; Remission Induction

2020
Treatment outcomes of advanced digestive well-differentiated grade 3 NETs.
    Endocrine-related cancer, 2021, 06-23, Volume: 28, Issue:8

    Topics: Adenocarcinoma; Etoposide; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Platinum; Retrospective Studies; Somatostatin; Treatment Outcome

2021
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.
    European journal of cancer (Oxford, England : 1990), 2017, Volume: 79

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cell Transformation, Neoplastic; Cisplatin; Cohort Studies; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Neoplasm Metastasis; Pancreatic Neoplasms; Prognosis

2017
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms.
    Journal of chemotherapy (Florence, Italy), 2018, Volume: 30, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Retrospective Studies; Stomach Neoplasms

2018
A case report of mixed acinar-endocrine carcinoma of the pancreas treated with S-1 chemotherapy: Does it work or induce endocrine differentiation?
    Medicine, 2017, Volume: 96, Issue:45

    Topics: Aged; Antineoplastic Agents; Carcinoma, Acinar Cell; Cisplatin; Deoxycytidine; Drug Combinations; Etoposide; Gemcitabine; Humans; Male; Oxonic Acid; Pancreatic Neoplasms; Tegafur

2017
Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3).
    Medical oncology (Northwood, London, England), 2018, Mar-06, Volume: 35, Issue:4

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Etoposide; Female; Humans; Infusions, Intravenous; Intestinal Neoplasms; Kaplan-Meier Estimate; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Proportional Hazards Models; Retrospective Studies; Stomach Neoplasms; Treatment Outcome

2018
[Conversion Surgery after Etoposide/Cisplatin(EP)Therapy for Huge Pancreatic Neuroendocrine Carcinoma - A Case Report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Pancreatic Neoplasms

2018
PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells.
    Oncogene, 2019, Volume: 38, Issue:22

    Topics: Animals; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; DNA Damage; DNA Repair; Epithelial-Mesenchymal Transition; Etoposide; Forkhead Box Protein M1; Gemcitabine; HEK293 Cells; Homeodomain Proteins; Humans; Liver Neoplasms; Mice; Mice, Knockout; Pancreas; Pancreatic Neoplasms; Protein Isoforms; Transcription, Genetic

2019
Small-cell neuroendocrine carcinoma of the uterine cervix with pancreatic metastasis: a case report and a review of the literature.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2019, Volume: 39, Issue:4

    Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Neoplasm Invasiveness; Palliative Care; Pancreatic Neoplasms; Uterine Cervical Neoplasms; Whole Body Imaging

2019
An exceptional case of atrial fibrillation arrhythmia induced by etoposide.
    Current drug safety, 2013, Volume: 8, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Atrial Fibrillation; Drug Monitoring; Etoposide; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms

2013
Etoposide induces apoptosis via the mitochondrial- and caspase-dependent pathways and in non-cancer stem cells in Panc-1 pancreatic cancer cells.
    Oncology reports, 2013, Volume: 30, Issue:6

    Topics: Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cytochromes c; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Mitochondria; Neoplastic Stem Cells; Pancreatic Neoplasms; Signal Transduction

2013
A striking, localized eruption.
    JAMA dermatology, 2014, Volume: 150, Issue:11

    Topics: Antineoplastic Agents, Phytogenic; Drug Eruptions; Erythema; Etoposide; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms

2014
Suppression of Reserve MCM Complexes Chemosensitizes to Gemcitabine and 5-Fluorouracil.
    Molecular cancer research : MCR, 2015, Volume: 13, Issue:9

    Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Membrane Permeability; Deoxycytidine; DNA Replication; Etoposide; Fluorouracil; Gemcitabine; Humans; Minichromosome Maintenance Proteins; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms

2015
Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms.
    Endocrine-related cancer, 2015, Volume: 22, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Etoposide; Female; Fluorouracil; Humans; Ki-67 Antigen; Leucovorin; Male; Middle Aged; Neuroendocrine Tumors; Organoplatinum Compounds; Pancreatic Neoplasms; Prognosis; Survival Analysis; Young Adult

2015
Cutaneous metastasis as an initial presentation of a non-functioning pancreatic neuroendocrine tumor.
    World journal of gastroenterology, 2015, Sep-07, Volume: 21, Issue:33

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Gastrectomy; Humans; Lymphatic Metastasis; Male; Metastasectomy; Middle Aged; Neoplasm Recurrence, Local; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Reoperation; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome

2015
Prognostic Significance of a Minute Amount of Ascites During Chemoradiotherapy for Locally Advanced Pancreatic Cancer.
    Anticancer research, 2016, Volume: 36, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascites; CA-19-9 Antigen; Chemoradiotherapy; Cisplatin; Deoxycytidine; Drug Combinations; Etoposide; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Oxonic Acid; Pancreatic Neoplasms; Prognosis; Tegafur; Tomography, X-Ray Computed

2016
Pancreatic lymphoma complicating early stage chronic hepatitis C.
    BMJ case reports, 2017, Jan-10, Volume: 2017

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Hepatitis C, Chronic; Humans; Pancreatic Neoplasms; Prednisone; Rituximab; Vincristine

2017
Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma--epigenetic downregulation of caspases.
    International journal of cancer, 2008, Oct-15, Volume: 123, Issue:8

    Topics: Animals; Apoptosis; Azacitidine; Carcinoma, Pancreatic Ductal; Caspases; Cell Line, Tumor; Cell Nucleus; Coculture Techniques; Decitabine; Deoxycytidine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Down-Regulation; Drug Resistance, Neoplasm; Epigenesis, Genetic; Etoposide; Female; Fibroblasts; Gemcitabine; Humans; Mice; Mice, SCID; Pancreatic Neoplasms; STAT1 Transcription Factor; Transfection

2008
Obstructive jaundice in a patient with mycosis fungoides metastatic to the pancreas. EUS findings.
    JOP : Journal of the pancreas, 2008, Nov-03, Volume: 9, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cholangiopancreatography, Endoscopic Retrograde; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Humans; Jaundice, Obstructive; Magnetic Resonance Imaging; Male; Middle Aged; Mycosis Fungoides; Pancreatic Neoplasms; Prednisone; Stents; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2008
Adenoviral-mediated gene transfer of Gadd45a results in suppression by inducing apoptosis and cell cycle arrest in pancreatic cancer cell.
    The journal of gene medicine, 2009, Volume: 11, Issue:1

    Topics: Adenoviridae; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Cycle; Cell Movement; Cells, Cultured; Cisplatin; Etoposide; Fluorouracil; GADD45 Proteins; Genetic Therapy; Genetic Vectors; Humans; Intracellular Signaling Peptides and Proteins; Pancreatic Neoplasms; Tumor Cells, Cultured

2009
alpha5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma.
    International journal of oncology, 2009, Volume: 34, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carcinoma, Pancreatic Ductal; Caspases; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Humans; Integrin alpha5; Mutagenesis, Site-Directed; Neural Cell Adhesion Molecule L1; Nitric Oxide Synthase Type II; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Transfection; Tumor Cells, Cultured

2009
Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer.
    Cancer science, 2009, Volume: 100, Issue:4

    Topics: Adenoviridae; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; beta-Galactosidase; Cell Line; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Electroporation; Etoposide; Fluorouracil; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Hepatocyte Growth Factor; Humans; Kidney; Mice; Mice, SCID; Pancreatic Neoplasms; Recombinant Proteins; Xenograft Model Antitumor Assays

2009
Small cell carcinoma of the pancreas: role of EUS-FNA and subsequent effective chemotherapy using carboplatin and etoposide.
    Journal of gastroenterology, 2009, Volume: 44, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Fine-Needle; Carboplatin; Carcinoma, Small Cell; Endosonography; Etoposide; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Tomography, X-Ray Computed; Ultrasonography, Interventional

2009
HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA.
    Gut, 2009, Volume: 58, Issue:10

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; DNA Damage; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Gene Expression Profiling; Gene Silencing; Histone Deacetylase 2; Histone Deacetylases; Humans; Neoplasm Proteins; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Repressor Proteins; Valproic Acid

2009
Isolated pancreatic metastases from a bronchogenic small cell carcinoma.
    Irish medical journal, 2009, Volume: 102, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bronchial Neoplasms; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Middle Aged; Pancreatic Neoplasms; Radiography; Ultrasonography

2009
Enhanced pancreatic cancer gene therapy by combination of adenoviral vector expressing c-erb-B2 (Her-2/neu)-targeted immunotoxin with a replication-competent adenovirus or etoposide.
    Human gene therapy, 2010, Volume: 21, Issue:2

    Topics: Adenocarcinoma; Adenoviridae; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Etoposide; Gene Targeting; Genetic Therapy; Genetic Vectors; Humans; Immunotoxins; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Pancreatic Neoplasms; Receptor, ErbB-2; Treatment Outcome; Virus Replication

2010
Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.
    Japanese journal of clinical oncology, 2010, Volume: 40, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Carcinoma, Neuroendocrine; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Retrospective Studies

2010
Characterization of BAG3 cleavage during apoptosis of pancreatic cancer cells.
    Journal of cellular physiology, 2010, Volume: 224, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Apoptosis Regulatory Proteins; Aspartic Acid; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cysteine Proteinase Inhibitors; Etoposide; Humans; Leupeptins; Mutation; Pancreatic Neoplasms; Peptide Fragments; Protein Processing, Post-Translational; Protein Structure, Tertiary; Recombinant Proteins; Staurosporine; Time Factors; Transfection; Tumor Necrosis Factor-alpha; Ultraviolet Rays

2010
Etoposide-loaded biodegradable amphiphilic methoxy (poly ethylene glycol) and poly (epsilon caprolactone) copolymeric micelles as drug delivery vehicle for cancer therapy.
    Drug delivery, 2010, Volume: 17, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Calorimetry, Differential Scanning; Cell Line, Tumor; Chromatography, High Pressure Liquid; Crystallization; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Etoposide; Humans; Inhibitory Concentration 50; Micelles; Molecular Weight; Pancreatic Neoplasms; Particle Size; Polyesters; Polyethylene Glycols

2010
Poorly differentiated endocrine carcinoma of the pancreas responded to gemcitabine: Case report.
    World journal of gastroenterology, 2010, Aug-14, Volume: 16, Issue:30

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Differentiation; Cisplatin; Deoxycytidine; Drug Administration Schedule; Endocrine Gland Neoplasms; Etoposide; Gemcitabine; Humans; Ileus; Irinotecan; Male; Middle Aged; Pancreatic Neoplasms; Tomography, X-Ray Computed; Treatment Failure

2010
Acinar Cell Carcinoma Responding to Carboplatin/Etoposide Chemotherapy.
    Journal of gastrointestinal cancer, 2012, Volume: 43 Suppl 1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Acinar Cell; Chromogranins; Etoposide; Humans; Keratins; Ki-67 Antigen; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Prognosis; Synaptophysin

2012
An unusual cause for weight loss and diabetes.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2011, Volume: 17, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Diabetes Mellitus; Etoposide; Glucagonoma; Humans; Liver Neoplasms; Male; Octreotide; Pancreatic Neoplasms; Weight Loss

2011
FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3.
    Endocrine-related cancer, 2012, Volume: 19, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptothecin; Carcinoma, Neuroendocrine; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Grading; Pancreatic Neoplasms; Pelvic Neoplasms; Platinum; Treatment Outcome

2012
JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report.
    Acta haematologica, 2013, Volume: 129, Issue:1

    Topics: Alleles; Antineoplastic Agents; Bone Marrow Neoplasms; Drug Therapy, Combination; Etoposide; Humans; Janus Kinase 2; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Mutation; Myeloproliferative Disorders; Pancreatic Neoplasms

2013
Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity.
    Oncogene, 2013, Volume: 32, Issue:40

    Topics: Alkaloids; Animals; Apoptosis; Cell Line, Tumor; Etoposide; Humans; Mice; Mice, SCID; NF-E2-Related Factor 2; Pancreatic Neoplasms; Proteasome Endopeptidase Complex; TNF-Related Apoptosis-Inducing Ligand; Xenograft Model Antitumor Assays

2013
Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death.
    International journal of cancer, 2013, May-15, Volume: 132, Issue:10

    Topics: Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Deoxycytidine; Disease Models, Animal; DNA Damage; Doxorubicin; Drug Synergism; Etoposide; Gemcitabine; Imidazoles; Immunohistochemistry; Immunoprecipitation; Indoles; Mice; Pancreatic Neoplasms; Piperazines; Proto-Oncogene Proteins c-mdm2; Pyrrolidinones; Topoisomerase II Inhibitors

2013
Neuroendocrine carcinoma of the pancreas with soft tissue metastasis.
    World journal of gastroenterology, 2012, Dec-07, Volume: 18, Issue:45

    Topics: Adult; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Laparotomy; Male; Neoplasm Metastasis; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Phosphopyruvate Hydratase; Positron-Emission Tomography; Soft Tissue Neoplasms; Splenectomy; Tomography, X-Ray Computed; Treatment Outcome

2012
Staging and treatment response evaluation in a metastatic neuroendocrine tumor of the pancreas with G2 grading: insights from multimodality diagnostic approach by F-18-FDG and Ga-68-DOTANOC PET/CT.
    Endocrine, 2013, Volume: 43, Issue:3

    Topics: Cisplatin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neuroendocrine Tumors; Pancreatic Neoplasms; Peptides, Cyclic; Radionuclide Imaging; Somatostatin; Treatment Outcome

2013
Carbon nanotubes enhance the internalization of drugs by cancer cells and decrease their chemoresistance to cytostatics.
    Nanotechnology, 2013, Feb-01, Volume: 24, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cytostatic Agents; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Humans; Metabolic Clearance Rate; Nanostructures; Nanotubes, Carbon; Pancreatic Neoplasms; Treatment Outcome

2013
Secondary pancreatic involvement by diffuse large B-cell lymphoma presenting as acute pancreatitis: treatment and outcome.
    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2002, Volume: 2, Issue:4

    Topics: Acute Disease; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Exocrine Pancreatic Insufficiency; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Pancreatic Neoplasms; Pancreatitis; Remission Induction; Tomography, X-Ray Computed

2002
Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer.
    International journal of cancer, 2003, Apr-20, Volume: 104, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Female; Gemcitabine; Humans; Mice; Mice, SCID; NF-kappa B; Pancreatic Neoplasms; Sulfasalazine; Tumor Cells, Cultured

2003
A case of aggressive neuroendocrine carcinoma of the stomach.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2003, Volume: 6, Issue:1

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Fluorouracil; Gastrectomy; Humans; Liver Neoplasms; Male; Middle Aged; Omentum; Pancreatic Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms; Tomography, X-Ray Computed

2003
Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.
    Oncogene, 2003, May-22, Volume: 22, Issue:21

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Apoptosis; Chromones; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Gemcitabine; Humans; Morpholines; NF-kappa B; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Tumor Cells, Cultured

2003
Chemosensitivity of human pancreatic carcinoma cells is enhanced by IkappaBalpha super-repressor.
    Cancer science, 2003, Volume: 94, Issue:5

    Topics: Adenoviridae; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cells, Cultured; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Gene Expression Profiling; Humans; I-kappa B Proteins; Neoplasm Proteins; NF-KappaB Inhibitor alpha; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Transfection

2003
Pyruvate inhibits zinc-mediated pancreatic islet cell death and diabetes.
    Diabetologia, 2003, Volume: 46, Issue:9

    Topics: Adenosine Triphosphate; Animals; Antigens, Polyomavirus Transforming; Antioxidants; Cell Death; Cell Line, Tumor; Cell Transformation, Neoplastic; Diabetes Mellitus, Experimental; Etoposide; Insulinoma; Interferon-gamma; Islets of Langerhans; NAD; Necrosis; Pancreatic Neoplasms; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Staurosporine; Tumor Necrosis Factor-alpha; Zinc

2003
The DNA damage-induced decrease of Bcl-2 is secondary to the activation of apoptotic effector caspases.
    Oncogene, 2003, Oct-09, Volume: 22, Issue:44

    Topics: Adenocarcinoma; Adenoviridae; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Apoptotic Protease-Activating Factor 1; Caspase Inhibitors; Caspases; Cell Transplantation; Dactinomycin; DNA Damage; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Enzyme Activation; Enzyme Inhibitors; Etoposide; Fibroblasts; Gene Deletion; Humans; Mice; Mice, SCID; Pancreatic Neoplasms; Proteins; Proto-Oncogene Proteins c-bcl-2; Transplantation, Heterologous; Tumor Cells, Cultured; Ultraviolet Rays

2003
[Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1].
    Deutsche medizinische Wochenschrift (1946), 2004, Mar-26, Volume: 129, Issue:13

    Topics: Anti-Ulcer Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Cisplatin; Clinical Trials as Topic; Doxorubicin; Etoposide; Gastrinoma; Gastrointestinal Agents; Humans; Insulinoma; Interferon-alpha; Multiple Endocrine Neoplasia Type 1; Neoplasm Metastasis; Octreotide; Omeprazole; Palliative Care; Pancreatectomy; Pancreatic Neoplasms; Prospective Studies; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Somatostatin; Streptozocin; Time Factors; Zollinger-Ellison Syndrome

2004
[Autocrine IL-1beta secretion leads to NF-kappabeta-mediated chemoresistance in pancreatic carcinoma cells in vivo].
    Medizinische Klinik (Munich, Germany : 1983), 2004, Apr-15, Volume: 99, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autocrine Communication; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Drug Resistance, Multiple; Etoposide; Female; Humans; In Situ Nick-End Labeling; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Mice; Mice, SCID; Neoplasm Transplantation; NF-kappa B; Pancreatic Neoplasms; Recombinant Proteins; Sialoglycoproteins; Tumor Cells, Cultured; Tumor Stem Cell Assay

2004
Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.
    Cancer research, 2005, Feb-15, Volume: 65, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; beta-Transducin Repeat-Containing Proteins; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Drug Resistance, Neoplasm; Etoposide; Humans; I-kappa B Proteins; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; NF-kappa B; Pancreatic Neoplasms; Sialoglycoproteins; Transfection

2005
In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Oct-15, Volume: 11, Issue:20

    Topics: Animals; Antineoplastic Agents; Apoptosis; BRCA2 Protein; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Chlorambucil; Cisplatin; Cross-Linking Reagents; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Fanconi Anemia Complementation Group C Protein; Fanconi Anemia Complementation Group G Protein; Fanconi Anemia Complementation Group Proteins; Female; Fluorouracil; Gemcitabine; Humans; Inhibitory Concentration 50; Melphalan; Mice; Mice, Nude; Mitomycin; Mutation; Paclitaxel; Pancreatic Neoplasms; Time Factors; Vinblastine; Xenograft Model Antitumor Assays

2005
Intravascular hemolysis as a complication of clostridium perfringens sepsis.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, May-20, Volume: 24, Issue:15

    Topics: Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Carcinoma, Small Cell; Cisplatin; Clostridium Infections; Clostridium perfringens; Etoposide; Hemolysis; Humans; Jaundice, Obstructive; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Systemic Inflammatory Response Syndrome

2006
Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.
    Oncogene, 2007, Apr-26, Volume: 26, Issue:19

    Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Pancreatic Ductal; Caspase Inhibitors; Caspases; Cell Adhesion; Cell Line, Tumor; Drug Resistance, Neoplasm; Etoposide; Humans; Interleukin-1beta; Neural Cell Adhesion Molecule L1; Nitric Oxide; Nitric Oxide Synthase Type II; Pancreatic Neoplasms; Tumor Cells, Cultured

2007
Precocious puberty because of a pancreatic neuroectodermal tumor.
    Journal of pediatric surgery, 2006, Volume: 41, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Neuroectodermal Tumors, Primitive; Pancreatic Neoplasms; Puberty, Precocious; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2006
Ectopic Cushing's syndrome due to concurrent corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) secreted by malignant gastrinoma.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2007, Volume: 115, Issue:1

    Topics: Adrenocorticotropic Hormone; Adult; Antineoplastic Combined Chemotherapy Protocols; Corticotropin-Releasing Hormone; Cushing Syndrome; Duodenal Neoplasms; Etoposide; Female; Gastrinoma; Humans; Hydrocortisone; Liver Neoplasms; Paclitaxel; Pancreatic Neoplasms

2007
Neuroendocrine tumor of the pancreas resulting in precocious puberty.
    Journal of pediatric surgery, 2007, Volume: 42, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Neuroectodermal Tumors, Primitive; Pancreatic Neoplasms; Puberty, Precocious; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2007
[Acinar cell carcinoma of the pancreas: a rare tumor with particular clinical and paraclinical presentation].
    La Revue de medecine interne, 2008, Volume: 29, Issue:12

    Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Acinar Cell; Cisplatin; Etoposide; Follow-Up Studies; Humans; Immunohistochemistry; Male; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Panniculitis, Nodular Nonsuppurative; Radiography, Abdominal; Skin; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2008
Granulocytic sarcoma of Core-binding Factor (CBF) acute myeloid leukemia mimicking pancreatic cancer.
    Leukemia research, 2008, Volume: 32, Issue:9

    Topics: Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; CA-19-9 Antigen; Carboplatin; Core Binding Factors; Diagnosis, Differential; Etoposide; Female; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Lipase; Magnetic Resonance Imaging; Pancreatic Neoplasms; Sarcoma, Myeloid

2008
Gut neuroendocrine tumors.
    Current therapy in endocrinology and metabolism, 1994, Volume: 5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Diazoxide; Etoposide; Fluorouracil; Gastrointestinal Neoplasms; Humans; Interferon-alpha; Neuroendocrine Tumors; Octreotide; Omeprazole; Pancreatic Neoplasms; Streptozocin

1994
Epirubicin, etoposide and cisplatin in advanced pancreatic carcinoma.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:8

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Humans; Male; Middle Aged; Pancreatic Neoplasms

1993
"Chemotherapy for unresectable pancreatoblastoma".
    Medical and pediatric oncology, 1996, Volume: 26, Issue:6

    Topics: Adolescent; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Etoposide; Fatal Outcome; Fluorouracil; Humans; Male; Pancreatic Neoplasms; Streptozocin; Vincristine

1996
[Biliary and pancreatic excretion of etoposide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:9

    Topics: Bile; Etoposide; Humans; Infusions, Intravenous; Metabolic Clearance Rate; Pancreatic Juice; Pancreatic Neoplasms; Pancreaticoduodenectomy

1996
In vitro chemosensitivity of human pancreatic cancer cell lines.
    International journal of pancreatology : official journal of the International Association of Pancreatology, 1996, Volume: 20, Issue:3

    Topics: Aged; Antimetabolites; Antineoplastic Agents; Carcinoma, Ductal, Breast; Cisplatin; DNA Replication; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Pancreatic Neoplasms; Time Factors; Toxicity Tests; Tumor Cells, Cultured

1996
Quantitative determination of apoptotic death in cultured human pancreatic cancer cells by propidium iodide and digitonin.
    Cancer letters, 1999, Aug-03, Volume: 142, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Count; Cell Division; Digitonin; Drug Screening Assays, Antitumor; Etoposide; Humans; Microscopy, Fluorescence; Pancreatic Neoplasms; Propidium; Trypan Blue; Tumor Cells, Cultured

1999
Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:8

    Topics: Adenoviridae; Apoptosis; Cell Cycle; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; Etoposide; Flow Cytometry; Gene Expression; Humans; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Telomerase; Time Factors; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1999
Extrapulmonary small-cell carcinoma: report of three cases and update of therapy and prognosis.
    The Netherlands journal of medicine, 2000, Volume: 56, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Esophageal Neoplasms; Etoposide; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prognosis; Prostatic Neoplasms; Radiotherapy, Adjuvant

2000
Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide.
    British journal of cancer, 2000, Volume: 82, Issue:11

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Base Sequence; DNA Primers; Etoposide; Humans; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Telomerase; Tumor Cells, Cultured; Up-Regulation

2000
Pancreatoblastoma treated by delayed operation after effective chemotherapy.
    Journal of pediatric surgery, 2000, Volume: 35, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Neoplasms, Germ Cell and Embryonal; Pancreatectomy; Pancreatic Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2000
Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin.
    Oncogene, 2001, Feb-15, Volume: 20, Issue:7

    Topics: Antineoplastic Agents; Carcinoma; DNA-Binding Proteins; Doxorubicin; Drug Resistance; Etoposide; Gliotoxin; Humans; I-kappa B Proteins; Leupeptins; NF-kappa B; NF-KappaB Inhibitor alpha; Pancreatic Neoplasms; Sulfasalazine

2001
Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines.
    Cancer research, 2002, Feb-01, Volume: 62, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; DNA Damage; Drug Resistance, Neoplasm; Etoposide; Humans; Interleukin-1; NF-kappa B; Pancreatic Neoplasms; Tumor Cells, Cultured

2002
Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation.
    Diabetes, 2002, Volume: 51, Issue:4

    Topics: Animals; Apoptosis; Carbon Monoxide; Cell Survival; Cycloheximide; Cysteine Proteinase Inhibitors; DNA Fragmentation; Enzyme Activation; Etoposide; Graft Survival; Guanylate Cyclase; Insulinoma; Islets of Langerhans; Islets of Langerhans Transplantation; Kinetics; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Pancreatic Neoplasms; Recombinant Proteins; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2002
Misleading leads: don't assume an alpha-fetoprotein secreting tumour is of germ cell or hepatic origin.
    Medical and pediatric oncology, 2002, Volume: 38, Issue:5

    Topics: Abdomen; Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Diagnosis, Differential; Etoposide; Humans; Immunohistochemistry; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Pancreatic Neoplasms; Pancreaticoduodenectomy; Status Epilepticus

2002
Chemotherapy for pancreaticoblastoma.
    Medical and pediatric oncology, 1992, Volume: 20, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Child, Preschool; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Humans; Male; Pancreatic Neoplasms; Teniposide; Vincristine

1992
Pancreatoblastoma: response to chemotherapy.
    Medical and pediatric oncology, 1991, Volume: 19, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Vinblastine; Vincristine

1991
Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.
    Cancer, 1991, Jul-15, Volume: 68, Issue:2

    Topics: Adenoma, Islet Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Carcinoma; Cisplatin; Etoposide; Female; Gastrins; Glucagon; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Remission Induction; Survival Rate

1991
Pancreatic adenocarcinoma responding to cisplatin based cytotoxic chemotherapy.
    Australian and New Zealand journal of medicine, 1991, Volume: 21, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Middle Aged; Pancreatic Neoplasms

1991
[Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:13

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Division; Cisplatin; Doxorubicin; Drug Synergism; Etoposide; Humans; Mice; Mice, Nude; Mitomycin; Neoplasm Transplantation; Nitrobenzenes; Pancreatic Neoplasms; Stomach Neoplasms

1991
Complete remission of refractory small cell carcinoma of the pancreas with cisplatin and etoposide.
    Cancer, 1989, Nov-15, Volume: 64, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Male; Middle Aged; Pancreatic Neoplasms; Remission Induction; Tomography, X-Ray Computed; Ultrasonography

1989
[Effect of etoposide for urogenital tumors].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:6

    Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Pancreatic Neoplasms; Podophyllotoxin; Prostatic Neoplasms; Rhabdomyosarcoma; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms

1985